Guidant To Seek Review Of $425 Mil. Patent Suit Arbitration Award To Cordis
This article was originally published in The Gray Sheet
Executive Summary
Guidant stent sales will not be affected by a June 5 arbitration panel finding that the firm infringed Johnson &Johnson/Cordis' Palmaz-Schatz patents, Guidant says